Fineotex Q4 FY26: A US Oilfield Acquisition Rewrites the Growth Equation

Fineotex Chemical Limited closed Q4 FY26 with a sharp jump in scale, largely driven by the integration of its US oilfield specialty chemicals acquisition, CrudeChem Technologies Group. On a consolidated basis, revenue from operations rose to 313.73 crore in Q4 FY26 from 119.79 crore in Q4 FY25, a 162% year-on-year increase. Profitability also grew in absolute terms, with PAT at 43.79 crore versus 20.13 crore a year ago.

The quarter was not just about higher revenue. Management positioned the period as an early proof point of the CrudeChem integration, pointing to improvements in operational efficiency, capacity utilization, execution capabilities, and scalability at the acquired business. At the same time, consolidated margins compressed, reflecting the realities of a changed business mix, logistics volatility, and a larger international footprint.

The quarter in numbers and what changed

In FY26, Fineotex reported consolidated revenue from operations of 772.23 crore, up from 533.33 crore in FY25. PAT increased to 125.01 crore from 109.21 crore. The investor presentation also highlighted return ratios and operating discipline, reporting ROIC of 31%, ROCE of 18%, and ROE of 15%, with working capital at 79 days for Q4 FY26.

The revenue mix also shifted materially toward exports. The company reported that international revenue contributed 70.16% of Q4 FY26 revenue, with domestic at 29.84%. This is consistent with the acquisition-led expansion in the US.

The headline is clear: scale has increased. The subtler takeaway is that the company is now digesting a structurally different business profile, and near-term margin comparisons to the pre-acquisition base need careful interpretation.

CrudeChem: growth engine with capacity expansion underway

CrudeChem Technologies Group is described as a US-based specialty chemical manufacturer supplying advanced chemical fluid additives and comprehensive oilfield chemicals solutions. Fineotex acquired a 53.33% controlling stake through a subsidiary.

Management repeatedly emphasized that the business is not only manufacturing. The operating model combines specialty chemical production, technical services, and last mile delivery. In North America, management highlighted that logistics discipline and customer service levels can be as important as product performance, especially when serving large global oilfield services customers.

The company is also investing to expand. In management commentary and the concall, Fineotex stated it is doubling manufacturing capacity at CrudeChem to address larger contracts and future growth. On the concall, management stated Fineotex has funded around USD 7 million of capex at CCT post acquisition.

There was also a clear timeline update on scale ambition. Management stated it is confident of reaching a USD 200 million revenue level at the CrudeChem business by 2028, and that this target was revised from 2030 to 2028. Management also indicated that the Q4 annualized run rate is approximately USD 90 million to USD 100 million.

Separately, management stated that a further 25% stake purchase in CrudeChem is planned for January 2028 as part of the agreement with founders, taking Fineotex to roughly 79% to 80% ownership.

The core business: textiles, hygiene and water still matter

Fineotex continues to present itself as a single stop sustainable solutions provider spanning oil and gas, textiles, FMCG cleaning and hygiene, and water treatment. In textiles, the company highlights the breadth of its offerings across the textile wet processing chain and positions itself as a customization-led, technical services-driven partner.

In the concall, management noted that demand conditions in textiles were stable and improving, and linked optimism to trade developments across the UK, EU and the US. While these points support a better sector narrative, there was no quantified segment revenue guidance. Management did, however, state that textile performance improved year-on-year in Q4 and also referenced a pickup in volumes.

On cleaning and hygiene, the investor deck positions the segment as a successful diversification, leveraging Fineotex manufacturing and distribution capabilities. On water treatment, the company mentions polymers under the Diaquest brand and frames the segment as a long-term growth lever alongside oil and gas.

Margins, working capital and what investors should track

Despite strong growth, consolidated EBITDA margin fell to 13.93% in Q4 FY26 from 17.77% in Q4 FY25. For FY26, EBITDA margin was 17.45% versus 23.85% in FY25. Management attributed the environment to logistics volatility, freight and container issues, and raw material availability constraints, while also stating the company has been able to pass on cost increases.

Management stated it is targeting a blended EBITDA margin in the range of 18% to 20% and that this could start reflecting within the current financial year, but did not provide formal quarter-wise guidance.

Working capital was discussed openly. The company reported working capital of 79 days in Q4 FY26. Management said that, given global uncertainty in logistics and raw material supply, higher inventories are a strategic requirement to protect customer service and deliveries, and that a cycle up to 90 days is manageable.

The balance sheet also shows the acquisition impact. Goodwill rose to 73.52 crore in FY26 from 6.14 crore in FY25, and non-controlling interest increased to 57.30 crore. These are typical in a consolidation following an acquisition, but they are important markers for investors tracking integration discipline and long-term return outcomes.

Takeaways

Fineotex’s Q4 FY26 performance marks a transition year. The company is now operating a broader specialty chemicals platform with a significant US oilfield chemicals exposure. The near-term focus is clear: scale CrudeChem, execute the capacity expansion, and normalize margins as operational efficiencies improve.

For investors, the most important next signals will be evidence of sustained margin improvement toward the 18% to 20% blended range discussed by management, working capital stability as international operations scale, and more granular disclosures that help validate the pace of the CrudeChem ramp-up. The company has put a high-growth aspiration on the table. Execution and transparency will determine how durable this step-change proves to be.